Literature DB >> 16145118

Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.

Jeffrey Parsonnet1, Melanie A Hansmann, Mary L Delaney, Paul A Modern, Andrea M Dubois, Wendy Wieland-Alter, Kimberly W Wissemann, John E Wild, Michaelle B Jones, Jon L Seymour, Andrew B Onderdonk.   

Abstract

Menstrual toxic shock syndrome (mTSS) is thought to be associated with colonization with toxic shock syndrome toxin 1 (TSST-1)-producing Staphylococcus aureus in women with insufficient antibody titers. mTSS has been associated with menstruation and tampon use, and although it is rare, the effects can be life threatening. It remains of interest because of the widespread use of tampons, reported to be about 70% of women in the United States, Canada, and much of Western Europe. This comprehensive study was designed to determine S. aureus colonization and TSST-1 serum antibody titers in 3,012 menstruating women in North America between the ages of 13 and 40, particularly among age and racial groups that could not be assessed reliably in previous small studies. One out of every four subjects was found to be colonized with S. aureus in at least one of three body sites (nose, vagina, or anus), with approximately 9% colonized vaginally. Eighty-five percent of subjects had antibody titers (> or =1:32) to TSST-1, and the vast majority (81%) of teenaged subjects (13 to 18 years) had already developed antibody titers. Among carriers of toxigenic S. aureus, a significantly lower percentage of black women than of white or Hispanic women were found to have antibody titers (> or =1:32) to TSST-1 (89% versus 98% and 100%). These findings demonstrate that the majority of teenagers have antibody titers (> or =1:32) to TSST-1 and are presumed to be protected from mTSS. These findings also suggest that black women may be more susceptible to mTSS than previously thought.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145118      PMCID: PMC1234102          DOI: 10.1128/JCM.43.9.4628-4634.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis.

Authors:  S K Sarafian; S A Morse
Journal:  J Med Microbiol       Date:  1987-08       Impact factor: 2.472

2.  Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1.

Authors:  J Parsonnet; J T Mills; Z A Gillis; G B Pier
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

3.  Nasal carriage of toxigenic Staphylococcus aureus and prevalence of serum antibody to toxic-shock-syndrome toxin 1 in Utah.

Authors:  J A Jacobson; E M Kasworm; B A Crass; M S Bergdoll
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

4.  Methods for quantitative and qualitative evaluation of vaginal microflora during menstruation.

Authors:  A B Onderdonk; G R Zamarchi; J A Walsh; R D Mellor; A Muñoz; E H Kass
Journal:  Appl Environ Microbiol       Date:  1986-02       Impact factor: 4.792

5.  Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8.

Authors:  J M Yarwood; P M Schlievert
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Toxic shock syndrome. II. Estimated occurrence in Colorado as influenced by case ascertainment methods.

Authors:  J K Todd; A M Wiesenthal; M Ressman; S A Caston; R S Hopkins
Journal:  Am J Epidemiol       Date:  1985-11       Impact factor: 4.897

7.  Toxic shock syndrome in the United States: surveillance update, 1979 1996.

Authors:  R A Hajjeh; A Reingold; A Weil; K Shutt; A Schuchat; B A Perkins
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

8.  Toxic shock syndrome toxin-1 (TSST-1) production and phage susceptibility of Staphylococcus aureus strains from human vaginas and anterior nares in Trinidad.

Authors:  A A Adesiyun; D Singh; R I Gunness
Journal:  Zentralbl Bakteriol       Date:  1994-01

9.  Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome.

Authors:  J M Vergeront; S J Stolz; B A Crass; D B Nelson; J P Davis; M S Bergdoll
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

10.  Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.

Authors:  P F Bonventre; M R Thompson; L E Adinolfi; Z A Gillis; J Parsonnet
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

View more
  43 in total

1.  A fatal case of staphylococcal toxic shock syndrome.

Authors:  Partha Roy; A K Sahni; Anshu Kumar
Journal:  Med J Armed Forces India       Date:  2013-08-02

2.  Staphylococcus aureus exotoxins are present in vivo in tampons.

Authors:  Patrick M Schlievert; Kimberly A Nemeth; Catherine C Davis; Marnie L Peterson; Bruce E Jones
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

3.  Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005.

Authors:  Patrick M Schlievert; Laura C Case; Kristi L Strandberg; Timothy J Tripp; Ying-Chi Lin; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

4.  Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

Authors:  Thu A Chau; Michelle L McCully; William Brintnell; Gary An; Katherine J Kasper; Enrique D Vinés; Paul Kubes; S M Mansour Haeryfar; John K McCormick; Ewa Cairns; David E Heinrichs; Joaquín Madrenas
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

5.  Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers.

Authors:  Bao G Vu; Christopher S Stach; Wilmara Salgado-Pabón; Daniel J Diekema; Sue E Gardner; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2014-06-20       Impact factor: 5.226

6.  Understanding toxic shock syndrome.

Authors:  Jason P Burnham; Marin H Kollef
Journal:  Intensive Care Med       Date:  2015-05-14       Impact factor: 17.440

Review 7.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

8.  Screening for staphylococcal superantigen genes shows no correlation with the presence or the severity of chronic rhinosinusitis and nasal polyposis.

Authors:  Frédéric Heymans; Adrien Fischer; Nicholas W Stow; Myriam Girard; Zacharias Vourexakis; Antoine Des Courtis; Gesuele Renzi; Elzbieta Huggler; Stefan Vlaminck; Pierre Bonfils; Ranko Mladina; Valerie Lund; Jacques Schrenzel; Patrice François; Jean Silvain Lacroix
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

9.  Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.

Authors:  Jeffrey Parsonnet; Melanie A Hansmann; Jon L Seymour; Mary L Delaney; Andrea M Dubois; Paul A Modern; Michaelle B Jones; John E Wild; Andrew B Onderdonk
Journal:  BMC Infect Dis       Date:  2010-08-23       Impact factor: 3.090

10.  Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.

Authors:  Eileen A Larkin; Bradley G Stiles; Robert G Ulrich
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.